Consolidated statement of changes in equity For the year ended 31 December 2018 Equity attributable Share to equity NonShare premium Own Other Translation Retained holders of controlling Total capital account shares reserves reserves earnings the parent interests equity m m m m m m m m m 1 January 2017 33.1 177.1 8.0 133.9 57.5 234.3 627.9 0.4 628.3 Net profit for the year 97.1 97.1 0.2 97.3 Exchange differences on translation of overseas operations 11.6 11.6 0.1 11.7 Actuarial losses on defined benefit pension schemes net of deferred tax 5.7 5.7 5.7 Total comprehensive income for the year 11.6 102.8 91.2 0.1 91.3 Acquired in the year settlement of share options 0.8 0.7 0.1 0.1 Share-based payments 7.8 7.8 7.8 Deferred tax on share-based payment transactions 0.6 0.6 0.6 Dividends paid 30.6 30.6 30.6 31 December 2017 33.1 177.1 7.2 141.0 45.9 307.1 697.0 0.5 697.5 Net profit for the year 103.2 103.2 0.4 103.6 Exchange differences on translation of overseas operations 16.0 16.0 0.2 15.8 Actuarial gains on defined benefit pension schemes net of deferred tax 1.3 1.3 1.3 Total comprehensive income for the year 16.0 101.9 117.9 0.2 118.1 Return of capital to shareholders and redemption of B shares 0.2 0.2 0.2 Acquired in the year settlement of share options 7.6 3.4 0.4 10.6 10.6 Share-based payments 3.8 3.8 3.8 Deferred tax on share-based payment transactions 0.2 0.2 0.2 Dividends paid 81.8 81.8 81.8 31 January 2018 33.1 177.1 14.8 141.4 61.9 327.2 725.9 0.7 726.6 Included in other reserves is the capital redemption reserve of 129.8m 2017: 129.8m and the share-based payments reserve of 10.8m 2017: 10.4m.
The own shares reserve represents the cost of shares in Bodycote plc purchased in the market.
At 31 December 2018, 1,839,860 2017: 1,171,190 ordinary shares of 17 3 11p each were held by the Bodycote International Employee Benefit Trust to satisfy share-based payments under the Groups incentive schemes see note 27.
